Multi-omics analysis reveals AR as a potential prognostic factor and immune-related therapeutic target in gastric cancer
In conclusion, this study highlights the potential of the AR as a novel biomarker for gastric cancer prognosis and immunotherapy efficacy, expanding its applicability in the development of new antitumor drugs.
Authors
- Sida Cheng (ORCID: https://orcid.org/0000-0003-1591-9581)
- Ruixuan Wang (ORCID: https://orcid.org/0000-0002-8714-0369)
- Zonghao Liu (ORCID: https://orcid.org/0009-0000-3456-1381)
- Yanlu Bai
- Jingya Zhang
- Linlin Gao
- Nan Xia
- Tianru Ben
Institutions
- Affiliated Hospital of Liaoning University of Traditional Chinese Medicine (CN)
- First Hospital of China Medical University (CN)
- China Medical University (CN)
Publication Details
- Journal
- Biochemistry and Biophysics Reports
- Published
- 2026-03-16
- DOI
- https://doi.org/10.1016/j.bbrep.2026.102537
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00